Logo
  • Home
  • About
  • What we do
  • Partners
  • News
  • Resources
  • Careers
  • Contact

15 Oct 2020  |  

Finding a link between the microbiome and disease

By Kathryn Morrissey for BioLizard

Written by Steff Taelman, a bioinformatics scientist at BioLizard nv.
Published in the October 2020 edition of MedNous, a publication of Evernow Publishing Ltd.

In 1884, Robert Koch identified a causal relationship between a certain Mycobacterium species and tuberculosis. As the backbone of this discovery, he postulated a four-step protocol for inferring simple causal relationships between bacteria and diseases, resulting in the additional discovery of pathogens inducing cholera and anthrax poisoning. Although his findings were considered a breakthrough in the understanding of infectious diseases, Koch’s postulates are largely obsolete. We now know that viral particles, as well as symbiotic, commensal, and predatory microbial interactions, are integral to our health and well-being as part of complex microbial ecosystems. Our bodies contain hundreds of trillions of bacterial, fungal, archaeal, and viral microbes. Although their impact on our health is yet to be fully understood, the abundance and diversity of these microbes has led to a recent explosion of microbiome research.

The current gold standard of causal inference is through randomised trials. However, pathogen and disease related trials raise a number of ethical conundrums, therefore microbiome research to date has mostly only produced associations and correlations to specific diseases (1). While informative in their own right, associations can lead to skewed interpretations of the causal mechanisms in a system. For instance, a study showed that babies delivered by cesarean sections have been associated with a higher rate of obesity. The hypothesis in this study was that if babies were delivered by caesarean section they were not exposed to maternal microbiota at birth, therefore heightening their chance of microbiome-related disorders later in life, such as obesity (2). However, the prevalence of caesarean sections has also been shown to be higher for obese mothers (3). Therefore, maternal obesity may be a common cause for caesarean sections and child obesity, with no real cause-effect relation between the latter two.

Causal discovery, however, can also be approached purely based on observational data. A collaboration between the Ghent University in Belgium and BioLizard NV, an informatics and machine learning consulting company in the field of life sciences, now aims to bring causal inference to microbiome research. While only controlled experiments can provide conclusive evidence of causal effects, a great deal of work can be done in silico, by generating testable hypotheses.

mednous

In ‘The Book of Why,’ Judea Pearl argues that there are three mathematically distinct levels of causal inference. The first is association which is described as being able to detect if some events are related, e.g., bacterium X is associated with an increased risk of gastric cancer. The second is intervention which is being able to predict possible effects of a given action, e.g., stimulating bacteriophage Y will reduce the risk of obesity. The third is counterfactual reasoning which is being able to reevaluate situations given that some circumstances are different, e.g., would a patient still have Covid-19 if she had a higher abundance of fungus Z in her gut? The vast majority of current machine learning methods are concerned only with the first level. This is also the case in microbiome research, where studies often show correlations and associations rather than causal mechanisms. Pearl argues that causal inference can only be derived from the causal graph, i.e., by making and testing assumptions on the mechanism of the systems of interest (2).

The second level is where pharmacological relevance of microbiome research comes into play. Some probiotics already exist that reduce the risk of Clostridium difficilerelated diarrhoea by diminishing its functional niche in the gut microbial community. Aside from probiotics, faecal transplants are also gaining a lot of interest, where ‘healthy’ microbiomes are transplanted to a person with obesity or Type 2 diabetes to counter the microbial influence on these ailments (3).

We now know that viral particles, as well as symbiotic, commensal, and predatory microbial interactions, are integral to our health and well-being as part of complex microbial ecosystems.

While these proposed treatments have shown promise in both mouse and human models, they are far from perfect. This is where the third level becomes important. When a drug or treatment shows high promise, yet is still ineffective, it is important to understand why this is the case and which conditions could be altered to improve the result. This kind of counterfactual reasoning is currently making its way into the state-of-the-art of machine learning, as it stands to reason that predictions can be made more accurately when the learning algorithm is fed a causal mechanism, rather than a series of associated factors (4). The collaborative work done between the Ghent University and our company BioLizard, approaches Pearl’s levels systematically. Starting from proven causal links, such as those observed between gastric cancer and Helicobacter pylori in the stomach microbiome or between dental plaque and Fusobacterium nucleatum in the oral microbiome, state-of-the-art causal inference models are being fit to the ecological systems of the human body. In silico frameworks developed through this research will either substantiate or refute the associative links made between the microbiome and disease, and could dramatically accelerate the development of drugs, biomarkers and personalised nutrition.

This research is supported by Flanders Innovation & Entrepreneurship (VLAIO) through the Baekeland grant HBC.2020.2292.

References:

1.Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017). The Human Microbiota in Health and Disease. In Engineering (Vol. 3, Issue 1, pp. 71–82). Elsevier Ltd.

2. Pearl, J., & Mackenzie, D. (2018). The Book of Why: the new science of cause and effect. In Notices of the American Mathematical Society. Basic Books.

3. Marotz, C. A., & Zarrinpar, A. (2016). Treating obesity and metabolic syndrome with fecal microbiota transplantation. In Yale Journal of Biology and Medicine (Vol. 89, Issue 3, pp. 383–388). Yale Journal of Biology and Medicine Inc.

4. Richens, J. G., Lee, C. M., & Johri, S. (2020). Improving the accuracy of medical diagnosis with causal machine learning. Nature Communications, 11(1), 1–9.

Related news

portfolio
08 August 2022

The first step in the journey from imprecise drug therapy to precision medicine – REPO4EU

BioLizard is proud to join the REPO4EU consortium.

Read more
portfolio
25 July 2022

BioLizard is now an Official Illumina Connected Analytics Implementation Partner

BioLizard is recognised as a skilled and competent service partner for ICA users.  

Read more
portfolio
19 January 2022

BioLizard enters into a strategic partnership with flanders.bio

We’re proud to officially announce that BioLizard begins its strategic partnership with flanders.bio.

Read more
portfolio
15 December 2021

BioLizard partners up with AutoML provider JADBio

BioLizard partners with JADBio, a leading provider of automated machine learning (AutoML) tools.  

Read more

Let's do something
great together

Contact us

Join the social
media discussion

Stay informed with
our latest news

Read our news
  • Home
  • About

©2022 BioLizard nv. All Rights Reserved. Design by Just Jax. Development by TYL.

  • Privacy Policy
Logo
Biolizard Cookie Consent Information

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.

Cookie SettingsAccept All

Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
bcookie2 yearsLinkedIn sets this cookie from LinkedIn share buttons and ad tags to recognize browser ID.
langsessionThis cookie is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc1 dayLinkedIn sets the lidc cookie to facilitate data center selection.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_gtag_UA_164325847_11 minuteThis cookie is set by Google and is used to distinguish users.
_gat_UA-164325847-11 minuteThis is a pattern type cookie set by Google Analytics, where the pattern element on the name contains the unique identity number of the account or website it relates to. It appears to be a variation of the _gat cookie which is used to limit the amount of data recorded by Google on high traffic volume websites.
_gcl_au3 monthsProvided by Google Tag Manager to experiment advertisement efficiency of websites using their services.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
_fbp3 monthsThis cookie is set by Facebook to display advertisements when either on Facebook or on a digital platform powered by Facebook advertising, after visiting the website.
bscookie2 yearsThis cookie is a browser ID cookie set by Linked share Buttons and ad tags.
fr3 monthsFacebook sets this cookie to show relevant advertisements to users by tracking user behaviour across the web, on sites that have Facebook pixel or Facebook social plugin.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
a3aa548f857642d7ad9818410843280acd93d104c52e466aa7c59da011282bb01 yearNo description
AnalyticsSyncHistory1 monthNo description
li_gc2 yearsNo description
UserMatchHistory1 monthLinkedin - Used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
SAVE & ACCEPT
Powered by CookieYes Logo